Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-011168

General Counsel sold 4,100 shares at $29.33 ($120,257)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-29 Sale : show line 1 in the form −4,100 $29.33 $120,257 18,680 D
Open-market sales · 4,100 sh · avg $29.33 · $120,257
Loading xslF345X05/form4.xml…